跳至主要内容
临床试验/EUCTR2004-000408-41-IT
EUCTR2004-000408-41-IT进行中(未招募)不适用

Randomized, Double-blind, Multicenter study to compare the safety and efficacy of Viramidine to Ribavirin in Treatment-Naive patients with Chronic Hepatitis C

RIBAPHARM0 个研究点开始时间: 2005年6月28日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

发起方
RIBAPHARM

相似试验

进行中(未招募)
1 期
Clinical study to investigate the efficacy and safety of a budesonide suppository for the treatment of acute ulcerative proctitisAcute ulcerative proctitis
EUCTR2012-003362-41-DEDr. Falk Pharma GmbH337
进行中(未招募)
不适用
Randomized, multicenter, double blind study to compare the efficacy and tolerability of Oleogel-S-10 for 3 months versus placebo only in patients with mild to moderate ac-tinic keratoses located at the face and head - BETA-TrialDie Studie ist eine randomisierte, multizentrische, doppelt verblindete Studie zum Vergleich der Wirksamkeit und Verträglichkeit einer Behandlung mit Oleogel-S-10 über 3 Monate vs. Placebo bei Patienten mit gering- bis mittelgradigen aktinischen Keratosen des Kopfes inkl. des Gesichtes. Ziel der Studie ist es, die Wirksamkeit und die Tolerabilität dieser Behandlung zu prüfen.
EUCTR2008-002632-15-DEBirken GmbH162
进行中(未招募)
不适用
Safety and Efficacy of the Combination of Loop With Thiazide-type Diureticsin Patients With Decompensated Heart Failure (CLOROTIC)
EUCTR2013-001852-36-ESSociedad Española de Medicina Interna
进行中(未招募)
不适用
Multi-center, double-blind, randomized study to investigate the impact of a sequential oral contraceptive containing estradiol valerate and dienogest (SH T00658ID) compared to a monophasic contraceptive containing ethinylestradiol and levonorgestrel (Microgynon) over 6 treatment cycles on alleviating complaints of reduced libido in women with acquired female sexual dysfunction (FSD) associated with oral contraceptive use
EUCTR2008-002263-13-DEBayer HealthCare AG216
进行中(未招募)
不适用
Multi-center, double-blind, randomized study to investigate the impact of a sequential oral contraceptive containing estradiol valerate and dienogest (SH T00658ID) compared to a monophasic contraceptive containing ethinylestradiol and levonorgestrel (Microgynon) over 6 treatment cycles on alleviating complaints of reduced libido in women with acquired female sexual dysfunction (FSD) associated with oral contraceptive use”Estudio multicéntrico, doble ciego, aleatorizado para investigar el impacto de un anticonceptivo oral secuencial que contiene estradiol valerate y dienogest ( SH T00658ID) comparado con un anticonceptivo monofásico que contiene etinilestradiol y levonorgestrel ( Microgynon) en 6 ciclos de tratamiento en el alivio de las quejas de disminución de la libido en las mujeres con disfunción sexual femenina adquirida, asociada con el uso de anticonceptivos orales.Reduced libido in women with acquired female sexual dysfunction (FSD) associated with oral contraceptive use.Disminución de la libido en mujeres con disfunción sexual femenina adquirida, asociada con el uso de anticonceptivos orales.MedDRA version: 9.1Level: LLTClassification code 10030970Term: Oral contraception
EUCTR2008-002263-13-ESBayer HealthCare AG216